跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,852 条关于
“Byers Capital”
全部
3,852
临床试验
634
药物
82
机构
122
资讯
3,014
去年
Octave Bioscience Secures $35.6M Series C Funding to Advance Multiple Sclerosis Precision Testing Platform
2年前
ArsenalBio Secures $325 Million in Series C Funding to Advance CAR T-Cell Therapies for Solid Tumors
去年
Leyden Labs Secures $70 Million to Advance Intranasal Antibody Therapies Against Respiratory Viruses
11个月前
Vial Initiates Phase 1 Trial of Novel INHBE siRNA Therapy for Obesity Treatment
去年
Vial Doses First Participants in Phase 1 Trial of Half-Life Extended Anti-TL1A Antibody for IBD Treatment
去年
Leyden Labs Secures €20 Million EIB Funding to Advance Pan-Influenza Nasal Spray Development
去年
Faron Pharmaceuticals' Bexmarilimab Shows Promise in Myelodysplastic Syndrome Treatment
去年
Bristol Myers Squibb and Bain Capital Launch $300M Immunology Drug Development Venture
去年
IGM Biosciences Downgraded by BMO Capital Following Strategic Update
去年
Bain Capital Acquires Mitsubishi Tanabe Pharma in $3.3 Billion Deal
第 1 页,共 302 页
上一页
下一页